GT Biopharma, Inc. (GTBP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.33M |
| Enterprise Value | -2.48M |
| P/E Ratio | -0.28 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.78 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.78 |
| Return On Equity | -9.01 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -28.23M |
| Net Income | -28.35M |
| Diluted EPS | -6.25 |
| Total Cash | 8.92M |
| Total Cash/Share | 0.29 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.69 |
| Book Value Per Share | 0.25 |
| 52-Week Change | -84.08 |
| 52-Week High | 3.85 |
| 52-Week Low | 0.26 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.59 |
| Average Volume | 1.31M |
| Shares Outstanding | 10.62M |
| % Held by Institutions | 29.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1:30 |
| Last Split Date | February 05, 2024 |